R. Kurzrock

The evolving landscape of tissue-agnostic therapies in precision oncology.

Mohamed A. Gouda, V. Subbiah, B. Ryll, 2024, CA: a cancer journal for clinicians.

Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study

J. Hainsworth, R. Bose, C. Swanton, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations

O. Tutar, Ashkan Adibi, Ü. M. Tokat, 2024, Therapeutic Advances in Medical Oncology.

Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins.

Elsa V. Arocho-Quinones, Ryuma Tanaka, R. Kurzrock, 2024, JCO precision oncology.

Higher tumor mutational burden and PD-L1 expression correlate with shorter survival in hematologic malignancies

Aaron Trando, R. Kurzrock, Ah-Reum Jeong, 2024, Therapeutic advances in medical oncology.

Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors

R. Schilsky, E. Rubin, C. Bresson, 2024, Therapeutic advances in medical oncology.